
FACT5270MR
- Status: Ongoing
- September 2022
- Healthcare
Radioimmunotherapy Market
Radioimmunotherapy (RIT) Market By Drug type (Ibritumomab, Rituximab, Epratuzumab, Tositumumab, Lintuzumab, Labetuzumab, Trastuzumab), By Application (Non Hodgkin Lymphoma (NHL), Follicular Lymphoma, Breast Cancer, Ovarian Cancer, Osteosarcoma, Melanoma, Leukemia) - Global Review 2020 to 2030
- Home
- Radioimmunotherapy Market
- Request for Brochure